logo-loader
LON:POLX

Polarean Imaging PLC

Receive alerts
Market:
LON
Market Cap:
£27.64 m
Price
£0.24
Change
0.63%
52 weeks high
31.70
52 weeks low
13.50

Viewing results 1-25 of 29

Tech

Amphion Innovations keen to hold onto Polarean Imaging stake

Amphion Innovations provides “concentrated but well-managed portfolio” in high growth sectors...

1 week, 3 days ago
Tech

Amphion Innovations keen to hold onto Polarean Imaging stake

Amphion Innovations provides “concentrated but well-managed portfolio” in high growth sectors...

1 week, 3 days ago
Health

Polarean Imaging on track to complete trial recruitment by the end of the current quarter after enrolment begins at third US site

MRI scans generally aren't much use when assessing lung function, but Polarean has developed a way in which a small amount of inert gas can change that...

2 weeks, 4 days ago
Tech

Polarean Imaging raises £2.1mln in share placing

“We are now entering a crucial period in Polarean's development and I look forward to providing our shareholders with further updates as appropriate," said chief executive Richard Hullihen....

on 22/7/19
Tech

University of Kansas Medical Center orders another of Polarean’s 9820 Xenon Polariser systems

The hyperpolarised 129-Xenon gas helps to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function...

on 11/7/19
Tech

Polarean Imaging reports slightly higher revenues and lower costs

"We have begun early discussions with potential strategic partners in the pharmaceutical industry and in other geographic markets that could lead to important developments in new applications and uses for our technology"...

on 27/6/19
Tech

Polarean Imaging on schedule for US launch of lung function scanner

Company has developed a drug-device combination, which uses hyperpolarised 129-Xenon gas MRI....

on 11/6/19
Tech

Polarean Imaging begins enrolling at third site for clinical trials of MRI lung scan

If approved by the FDA, commercial launch of the combined drug-device product is expected to occur during the second half of 2020, as previously indicated...

on 11/6/19
Tech

Polarean Imaging receives system order from Canadian children’s hospital

The order for the 9820 Xenon Polariser system will take the total number of Polarean's polarisers installed or on order to 24...

on 5/6/19
Tech

Polarean Imaging to receive third tranche of research grant

The grant was awarded from the National Heart, Lung and Blood Institute to Polarean and Cincinnati Children's Hospital Center. The money will continue to fund an ongoing Phase III trial evaluating the use of 129 Xe MRI scanning on children suffering from cystic fibrosis....

on 21/5/19
Tech

Polarean adds third trial site to late-stage study of its lung MRI scan technology

MRI scans generally aren’t very useful in assessing lung function, but Polarean’s 129Xe gas is trying to change that...

on 13/5/19
Tech

Polarean Imaging appoints former CFO of cancer therapeutics firm as new finance boss

Charles (Chuck) Osborne, Jr joins the company from oncology group Innocrin Pharmaceuticals and would start the role with immediately...

on 29/4/19
Tech

Amphion Innovations provides “concentrated but well-managed portfolio” in high growth sectors

The company invests and helps build companies in the medical and technology sectors, with a target exit valuation of over US$100mln...

on 19/3/19
Tech

Polarean Imaging signs deal with University of British Colombia

CEO Richard Hullihen said: “UBC has a long history and pioneering reputation in the field of medical imaging research and I look forward to providing further updates regarding our collaboration with UBC as appropriate.”...

on 15/2/19
Tech

Amphion Innovations still looking at funding options; unsure why shares have surged of late

“The company remains cash constrained and as previously announced continues to consider both its short term and medium-term funding options and work with the company's debt providers”...

on 7/2/19
Tech

City broker reckons Polarean shares are worth three times their current value

“The annual burden of pulmonary disease in the US is estimated to be over US$150bn and Polarean expects over US$500mln in system sales just to top-tier institutes,” read Northland’s note...

on 11/12/18
Tech

Amphion Innovations agrees loan facility top up

Following drawdown of the new funds, the balance on the loan facility will be US$4.23mln...

on 16/10/18
Tech

Amphion Innovations lines up FireStar for 2019 IPO

Another of Amphion’s investee companies, Polarean Imaging, was floated on AIM earlier this year, and FireStar is the next one earmarked to go public...

on 28/9/18